68 related articles for article (PubMed ID: 10689413)
1. Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
Gordon SC
Postgrad Med; 2000 Feb; 107(2):135-8, 141-4. PubMed ID: 10689413
[TBL] [Abstract][Full Text] [Related]
2. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic viral hepatitis].
Pedersen C; Pedersen CR
Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
[TBL] [Abstract][Full Text] [Related]
6. Current treatment strategies for chronic hepatitis B and C.
Lin OS; Keeffe EB
Annu Rev Med; 2001; 52():29-49. PubMed ID: 11160766
[TBL] [Abstract][Full Text] [Related]
7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
8. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
[TBL] [Abstract][Full Text] [Related]
10. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
[No Abstract] [Full Text] [Related]
11. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
Schvarcz R; Ando Y; Sönnerborg A; Weiland O
J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
[TBL] [Abstract][Full Text] [Related]
13. Can science meet the challenges of the HCV pandemic: new treatment options for chronic hepatitis C.
Roehr B
J Int Assoc Physicians AIDS Care; 1998 Jul; 4(7):24-9. PubMed ID: 11365638
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis.
Gow PJ; Mutimer D
BMJ; 2001 Nov; 323(7322):1164-7. PubMed ID: 11711410
[No Abstract] [Full Text] [Related]
15. [Chronic hepatitis--new therapeutic options].
Arnold JC; Stremmel W
Internist (Berl); 2001 Apr; 42(4):516-22. PubMed ID: 11326734
[No Abstract] [Full Text] [Related]
16. Therapy of chronic hepatitis B and C and treatment options in HCV-HIV co-infection--European Conference on Infectious Diseases and Tropical Medicine, EuCID 2001, 3-6 May 2001, Leipzig.
Tossing G
Eur J Med Res; 2001 Jun; 6(6):272-4. PubMed ID: 11432799
[TBL] [Abstract][Full Text] [Related]
17. [Role of interferons in the treatment of hepatitis B and hepatitis C virus infections].
Cacoub P; Benhamou Y
Rev Med Interne; 2002 Nov; 23 Suppl 4():459s-474s. PubMed ID: 12481401
[TBL] [Abstract][Full Text] [Related]
18. Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence.
Thomas DL
Top Antivir Med; 2014 Jan; 21(5):152-6. PubMed ID: 24531555
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Małkowski P; Pawłowska M; Simon K;
Przegl Epidemiol; 2010; 64(1):81-2. PubMed ID: 20499665
[No Abstract] [Full Text] [Related]
20. [Clinical response to combined treatment with reaferon and iodantipirin in patients with chronic HCV- and HBV-infection].
Beloborodova EI; Vnushinskaia MA; Rachkovskiĭ MI; Shalovaĭ AA; Timoshchuk OA; Khudoleĭ NV
Klin Med (Mosk); 2002; 80(4):52-4. PubMed ID: 12043266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
